|

Digital App for Speech & Health Monitoring

RECRUITINGSponsored by University of Edinburgh
Actively Recruiting
SponsorUniversity of Edinburgh
Started2024-07-12
Est. completion2026-06
Eligibility
Age16 Years+
Healthy vol.Accepted

Summary

Many people living with neurodegenerative conditions like dementia, motor neuron disease (MND), multiple sclerosis (MS), and Parkinson's disease (PD), suffer from speech problems. Using common digital technologies such as smartphone apps, the investigators can record and analyse speech in detail to provide new information for people living with these conditions, researchers, and healthcare professionals. This study will investigate the use of these digital speech recordings to help diagnose and monitor these conditions. To take part, participants will have either a diagnosis of dementia, motor neuron disease, Parkinson's disease or Multiple Sclerosis, OR they will have no diagnosis of a neurological condition. Researchers will compare people with a diagnosis of a Neurological condition to those without.

Eligibility

Age: 16 Years+Healthy volunteers accepted
Inclusion Criteria - Any one of the following:

* A person with a diagnosis of Motor Neuron Disease, Dementia, Multiple Sclerosis, or Parkinson's Disease.
* A relative or carer of the above who does not report to have a neurological condition.
* A healthy volunteer who does not report to have a neurological condition.

Exclusion Criteria:

* Age \<16 years
* Significant and uncorrected visual or hearing impairment (precluding use of the App).
* Lack capacity to consent to project due to cognitive impairment (precluding understanding of the study and use of the App).

Conditions4

DementiaMotor Neuron DiseaseMultiple SclerosisParkinson Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.